|
Volumn 18, Issue 1, 2001, Pages 11-15
|
Insulin sensitizer combination therapy for type 2 diabetes
|
Author keywords
[No Author keywords available]
|
Indexed keywords
2,4 THIAZOLIDINEDIONE DERIVATIVE;
ALPHA GLUCOSIDASE INHIBITOR;
GLUCOSE;
HEMOGLOBIN A1C;
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
INSULIN;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
MEGLITINIDE;
METFORMIN;
PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;
PIOGLITAZONE;
ROSIGLITAZONE;
SULFONYLUREA DERIVATIVE;
CLINICAL TRIAL;
COMBINATION CHEMOTHERAPY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG MECHANISM;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
HYPERGLYCEMIA;
IMMUNOPATHOGENESIS;
INSULIN RESISTANCE;
INSULIN SENSITIVITY;
MAJOR CLINICAL STUDY;
META ANALYSIS;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PATHOPHYSIOLOGY;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
|
EID: 0035145243
PISSN: 10926607
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (3)
|
References (13)
|